| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 7 |
| 1 | PREDNISOLONE ORAL | 7 |
| 2 | PREDNISOLONE ORAL SOLUTION | 7 |
| 3 | TOCILIZUMAB | 7 |
| 4 | OXYCODONE HYDROCHLORIDE | 6 |
| 5 | PACLITAXEL | 6 |
| 6 | CARBOPLATIN | 5 |
| 7 | ADALIMUMAB | 4 |
| 8 | BEVACIZUMAB | 4 |
| 9 | NINTEDANIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VADADUSTAT | 1 | 0.0033 |
| 1 | MOSUNETUZUMAB | 1 | 0.0009 |
| 2 | ZOLBETUXIMAB | 1 | 0.0007 |
| 3 | RAMUCIRUMAB | 2 | 0.0003 |
| 4 | GRANISETRON HYDROCHLORIDE | 3 | 0.0003 |
| 5 | CABAZITAXEL | 1 | 0.0003 |
| 6 | TENAPANOR HYDROCHLORIDE | 1 | 0.0003 |
| 7 | LEVALBUTEROL TARTRATE | 1 | 0.0003 |
| 8 | PHENAZOPYRIDINE | 1 | 0.0003 |
| 9 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 | 0.0001 |
| 6 | Glinide [EPC] | 1 | 0.0001 |
| 7 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |